Firebrick Pharma

(ASX) FRE

Current PriceA$0.04

Market CapA$11.12M

Since IPO (2022)-93%

5 YearN/A

1 Year-47%

1 Month-15%

Firebrick Pharma Financials at a Glance

Market Cap

A$11.12M

Revenue (TTM)

A$1.51M

Net Income (TTM)

-A$4.18M

EPS (TTM)

-A$0.01

P/E Ratio

-3.68

Dividend

A$0.00

Beta (Volatility)

0.16 (Low)

Dividend

A$0.00

Beta (Volatility)

0.16 (Low)

Price

A$0.04

Volume

42,824

Open

A$0.04

Price

A$0.04

Volume

42,824

Open

A$0.04

Previous Close

A$0.04

Daily Range

A$0.04 - A$0.04

52-Week Range

A$0.04 - A$0.09

Estimated Earnings Date

Nov 15, 2024

Dividend

A$0.00

Beta (Volatility)

0.16 (Low)

Price

A$0.04

Volume

42,824

Open

A$0.04

Previous Close

A$0.04

Daily Range

A$0.04 - A$0.04

52-Week Range

A$0.04 - A$0.09

Estimated Earnings Date

Nov 15, 2024

FRE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Firebrick Pharma

Industry

Pharmaceuticals

Sector

Health Care

CEO

Peter Laurence Molloy, PhD, MBA

Website

www.firebrickpharma.com

Headquarters

Melbourne, VIC 3000, AU

FRE Financials

Key Financial Metrics (TTM)

Gross Margin

-68%

Operating Margin

-6%

Net Income Margin

-6%

Return on Equity

-143%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

-27.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$11.12M

Shares Outstanding

285.20M

Volume

42.82K

Avg. Volume

228.82K

Financials (TTM)

Gross Profit

A$104.82K

Operating Income

-A$2.87M

EBITDA

-A$2.86M

Operating Cash Flow

-A$1.78M

Capital Expenditure

-A$82.98K

Free Cash Flow

-A$1.86M

Cash & ST Invst.

A$983.35K

Total Debt

A$0.00

Firebrick Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

A$63.27K

-93.0%

Gross Profit

-A$447.34K

-149.5%

Gross Margin

-7.07%

N/A

Market Cap

A$11.12M

N/A

Market Cap/Employee

A$1.85M

N/A

Employees

N/A

Net Income

-A$1.26M

-40.6%

EBITDA

-A$1.29M

-44.6%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

A$1.44M

+10.0%

Total Debt

A$0.00

N/A

Accounts Receivable

A$39.09K

+630.2%

Inventory

A$513.21K

+81.2%

Long Term Debt

A$0.00

N/A

Short Term Debt

A$0.00

N/A

Return on Assets

-1.07%

N/A

Return on Invested Capital

-1.21%

N/A

Free Cash Flow

-A$1.05M

-3.9%

Operating Cash Flow

-A$1.05M

-3.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NTI.AXNeurotech International Limited

NTI.AXNeurotech International LimitedA$0.01+8.33%

IMC.AXImmuron Limited

IMC.AXImmuron LimitedA$0.03-12.82%

MDR.AXMedAdvisor Limited

MDR.AXMedAdvisor LimitedA$0.02+0.00%

PAB.AXPatrys Limited

PAB.AXPatrys LimitedA$0.04+2.38%

TRP.AXTissue Repair Ltd

TRP.AXTissue Repair LtdA$0.11+4.76%

BTC.AXBTC Health Limited

BTC.AXBTC Health LimitedA$0.05+0.00%

AGH.AXAlthea Group Holdings Limited

AGH.AXAlthea Group Holdings LimitedA$0.02-4.76%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

Questions About FRE

What is the current price of Firebrick Pharma?

Firebrick Pharma is trading at A$0.04 per share.

What is the 52-week range for Firebrick Pharma?

Over the past 52 weeks, Firebrick Pharma has traded between A$0.04 and A$0.09.

How much debt does Firebrick Pharma have?

As of the most recent reporting period, Firebrick Pharma reported total debt of A$0.00.

How much cash does Firebrick Pharma have on hand?

Firebrick Pharma reported A$983.35K in cash and cash equivalents in its most recent financial results.

What is Firebrick Pharma’s dividend yield?

Firebrick Pharma does not currently have a dividend yield.

Firebrick Pharma

Firebrick Pharma Financials at a Glance

FRE News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Firebrick Pharma

FRE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Firebrick Pharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About FRE

What is the current price of Firebrick Pharma?

What is the 52-week range for Firebrick Pharma?

How much debt does Firebrick Pharma have?

How much cash does Firebrick Pharma have on hand?

What is Firebrick Pharma’s dividend yield?

Premium Investing Services